# Pulsecare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pulsecare

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.pulsecare.cn
- Total disclosed funding: $14M
- Latest round: Series A (Nov 6, 2025)
- Investors on record: 6

## About

Founded in 2021 and based in Shenzhen, China, Pulsecare operates as a medical devices provider that focuses on innovative minimally invasive therapeutic. The company's founder, Jianwen Tan, worked at state key laboratory of ultrasound medical engineering of Chongqing Medical University. The company's core team has over 20 years of experience in high pressure pulse therapy and 16 years in ultrasound therapy. In November 2025, Pulsecare closed a Series A+ funding led by new investor Oriza Holdings, new investor Loyal Valley Capital, with participation from returning investors Tsinghua Innovation Ventures and Tianfeng Capital.

The company's main business is the research and development, production, and sales of innovative medical devices. The company's self-developed technologies include pulsed electric field ablation platforms, integrated ultrasound diagnosis and treatment platforms, radiofrequency energy platforms, and plasma energy platforms.

Pulsecare generates revenue by providing medical devices and solutions to the healthcare industry.

The funding raised in November 2025 will be primarily used for: accelerating the commercialization of its core product, the NxPFA® nanosecond pulsed electric field ablation system; deepening the development of comprehensive cardiac electrophysiology solutions centered on nsPFA technology; comprehensively advancing the multi-center registration clinical research and subsequent registration application of the industry's first acoustically adjustable renal artery ultrasound neuroablation (muRDN) system in the field of interventional hypertension treatment.

## Funding rounds

- Series A, Nov 6, 2025 — Oriza Holdings, Loyal Valley Capital, Tsinghua Innovation Ventures, Tianfeng Capital
- Series A, Aug 22, 2024, $14M — Delian Capital, Tianfeng Capital, Tasly Capital Holdings Limited

## Investors

- Delian Capital (https://capitalatlas.ai/funds/delian-capital) — Series A
- Tianfeng Capital (https://capitalatlas.ai/funds/tianfeng-capital) — Series A
- Tasly Capital Holdings Limited (https://capitalatlas.ai/funds/tasly-capital-holdings-limited) — Series A
- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Series A
- Loyal Valley Capital (https://capitalatlas.ai/funds/loyal-valley-capital) — Series A
- Tsinghua Innovation Ventures (https://capitalatlas.ai/funds/tsinghua-innovation-ventures) — Series A